JP2020519293A5 - - Google Patents

Download PDF

Info

Publication number
JP2020519293A5
JP2020519293A5 JP2019562424A JP2019562424A JP2020519293A5 JP 2020519293 A5 JP2020519293 A5 JP 2020519293A5 JP 2019562424 A JP2019562424 A JP 2019562424A JP 2019562424 A JP2019562424 A JP 2019562424A JP 2020519293 A5 JP2020519293 A5 JP 2020519293A5
Authority
JP
Japan
Prior art keywords
seq
sequence identity
mtcr
cell receptor
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019562424A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020519293A (ja
JP7169298B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/030637 external-priority patent/WO2018208553A1/en
Publication of JP2020519293A publication Critical patent/JP2020519293A/ja
Publication of JP2020519293A5 publication Critical patent/JP2020519293A5/ja
Application granted granted Critical
Publication of JP7169298B2 publication Critical patent/JP7169298B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019562424A 2017-05-12 2018-05-02 ヒトアルファフェトタンパク質特異的t細胞受容体およびその使用 Expired - Fee Related JP7169298B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201762505406P 2017-05-12 2017-05-12
US62/505,406 2017-05-12
US201762609614P 2017-12-22 2017-12-22
US62/609,614 2017-12-22
US201862625051P 2018-02-01 2018-02-01
US62/625,051 2018-02-01
PCT/US2018/030637 WO2018208553A1 (en) 2017-05-12 2018-05-02 Human alpha fetoprotein-specific t cell receptors and uses thereof

Publications (3)

Publication Number Publication Date
JP2020519293A JP2020519293A (ja) 2020-07-02
JP2020519293A5 true JP2020519293A5 (enExample) 2021-06-10
JP7169298B2 JP7169298B2 (ja) 2022-11-10

Family

ID=64095949

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019562424A Expired - Fee Related JP7169298B2 (ja) 2017-05-12 2018-05-02 ヒトアルファフェトタンパク質特異的t細胞受容体およびその使用

Country Status (8)

Country Link
US (2) US11041011B2 (enExample)
EP (1) EP3622074A4 (enExample)
JP (1) JP7169298B2 (enExample)
KR (1) KR20200006985A (enExample)
CN (1) CN110662760A (enExample)
AU (1) AU2018266562A1 (enExample)
SG (1) SG11201909751TA (enExample)
WO (1) WO2018208553A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3622074A4 (en) 2017-05-12 2021-01-13 Augusta University Research Institute, Inc. HUMAN ALPHA FETOPROTEIN SPECIFIC T CELL RECEPTORS AND THEIR USES
CN110776562B (zh) * 2018-07-30 2022-06-17 香雪生命科学技术(广东)有限公司 一种识别afp抗原的t细胞受体
CN113072636B (zh) * 2020-01-06 2024-05-28 香雪生命科学技术(广东)有限公司 一种识别afp的t细胞受体及其编码序列
CN113321725B (zh) * 2020-02-28 2024-06-11 香雪生命科学技术(广东)有限公司 一种识别afp的t细胞受体
CN113684258B (zh) * 2020-05-18 2024-08-20 上海赛比曼生物科技有限公司 用于检测鼠源tcr转基因拷贝数的试剂盒及方法
CN115181177A (zh) * 2021-04-02 2022-10-14 香雪生命科学技术(广东)有限公司 针对afp的t细胞受体
EP4347644A4 (en) * 2021-05-31 2026-01-14 Nanjing Legend Biotech Co Ltd ANTIBODIES TARGETTING AFP/MHC PEPTIDE COMPLEXES AND THEIR USES
CN114121142B (zh) * 2021-09-02 2023-10-31 四川大学华西医院 一种新型基因修饰增强型ny-eso-1特异型tcr-t模型构建方法及应用
CN114853880B (zh) * 2022-04-24 2023-11-10 中国科学院微生物研究所 Wt1抗原特异性t细胞受体及其抗肿瘤用途
US20260226184A1 (en) * 2023-01-26 2026-08-06 Dana-Farber Cancer Institute, Inc. Developing a car-engager platform to enhance the functionality and/or persistence of car t cells

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2975607B2 (ja) 1989-03-16 1999-11-10 三洋電機株式会社 Afc回路
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
US5859205A (en) 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
DE69334275D1 (de) 1992-08-21 2009-05-20 Univ Bruxelles Immunoglobuline ohne Leichtkette
US6005079A (en) 1992-08-21 1999-12-21 Vrije Universiteit Brussels Immunoglobulins devoid of light chains
WO1994025591A1 (en) 1993-04-29 1994-11-10 Unilever N.V. PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE)
GB9325182D0 (en) 1993-12-08 1994-02-09 T Cell Sciences Inc Humanized antibodies or binding proteins thereof specific for t cell subpopulations exhibiting select beta chain variable regions
US20090304657A1 (en) 2006-05-03 2009-12-10 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Chimeric t cell receptors and related materials and methods of use
EP1878744A1 (en) 2006-07-13 2008-01-16 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Epitope-tag for surface-expressed T-cell receptor proteins, uses thereof and method of selecting host cells expressing them
US8105831B2 (en) * 2007-03-09 2012-01-31 University Of Washington Parvoviral production of HLA homozygous cells
EP2504358B1 (en) 2009-11-24 2016-10-19 ChronTech Pharma AB T cell receptors specific for immunodominant ctl epitopes of hcv
ES2635335T3 (es) * 2010-09-20 2017-10-03 Biontech Cell & Gene Therapies Gmbh Receptores de células T específicos de antígeno y epítopos de células T
GB201313377D0 (en) 2013-07-26 2013-09-11 Adaptimmune Ltd T cell receptors
EP3043641B1 (en) * 2013-09-12 2019-09-11 Icahn School of Medicine at Mount Sinai Methods of making transgenic animals with t cell receptors that are specific to a flourescent protein
CN104087592B (zh) * 2014-05-13 2016-01-27 天津医科大学总医院 Afp158-166特异性tcr基因及其转基因t细胞及体外增殖方法及用途
SG10201913978RA (en) * 2014-11-26 2020-03-30 The United States Of America As Represented By The Secretary Anti-mutated kras t cell receptors
CN105802909B (zh) * 2014-12-31 2021-01-01 中国医学科学院基础医学研究所 具有her2特异性tcr的t细胞制备物及其用途
EP3622074A4 (en) 2017-05-12 2021-01-13 Augusta University Research Institute, Inc. HUMAN ALPHA FETOPROTEIN SPECIFIC T CELL RECEPTORS AND THEIR USES

Similar Documents

Publication Publication Date Title
US11685789B2 (en) CD47 antigen-binding molecules
JP5738294B2 (ja) 抗vegfモノクローナル抗体およびその抗体を含む薬学的組成物
US11078273B2 (en) ROR2 antibody compositions and related methods
HRP20220131T1 (hr) Nova terapija s t-staničnim receptorima i imunološka terapija koja koristi iste
JP2013529070A5 (enExample)
JP2020517287A5 (enExample)
JP2012012402A5 (enExample)
JP2020500510A5 (enExample)
RU2014118555A (ru) Химерные антигенные рецепторы к cd22
HRP20190472T1 (hr) Klaudin-6 specifični imunoreceptori i t-stanični epitopi
JP2017532952A5 (enExample)
RU2017134140A (ru) Конструкции, направленные на комплексы пептида аfp/мнс, и виды их использования
JP2017537919A5 (enExample)
JP2014524733A5 (enExample)
RU2013141976A (ru) Новые модуляторы и способы их применения
JP2012523848A5 (enExample)
JP2012501670A5 (enExample)
JP2018518152A5 (enExample)
CN111183159A (zh) 靶向cd137的抗体及其使用方法
WO2014012007A4 (en) Rspo3 binding agents and uses thereof
JP2021501567A5 (enExample)
EP3636284A1 (en) Binding protein-toxin conjugates comprising anthracyclines, and use thereof in immune-oncological applications
JP2021505663A5 (enExample)
CN115605513A (zh) 一种抗pd-l1和her2的双特异性抗体
CN119899267A (zh) 拮抗性pd-1、pd-l1和lag-3结合蛋白